🔎 Trials Near Me

Hjem › Gliom › Texas › Houston

Gliom kliniske forsøg i Houston, TX

23 studier for Gliom søger deltagere på steder i og omkring Houston (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

RekruttererFase 1/2
  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
  • UT MD Anderson Cancer Center, Houston
12 Months – 21 Years · Alle køn · Opdateret 1. okt. 2026 · NCT05099003

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

RekruttererFase 1/2
  • Baylor College of Medicine, Houston
Op til 25 år · Alle køn · Opdateret 25. sep. 2026 · NCT04094610

MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma

RekruttererFase 1
  • M D Anderson Cancer Center, Houston
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT03896568

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

RekruttererFase 2
  • Texas Children's Hospital, Houston
12 Months – 39 Years · Alle køn · Opdateret 21. sep. 2026 · NCT06838676

MRE Scan for the Assessment of Differences in Tissue Stiffness Between Radiation Necrosis and Recurrent Glioma in Patients With Previously Treated Gliomas

Rekrutterer
  • M D Anderson Cancer Center, Houston
Alder 18 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT04373720

Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma

RekruttererObservationsstudie
  • M D Anderson Cancer Center, Houston
Alder 18 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT04771806

Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation

RekruttererFase 1
  • The University of Texas M. D. Anderson Cancer Center, Houston
36 Months · Alle køn · Opdateret 9. sep. 2026 · NCT07076498

Targeted Pediatric High-Grade Glioma Therapy

RekruttererObservationsstudie
  • Texas Children's Hospital, Houston
12 Months – 39 Years · Alle køn · Opdateret 8. sep. 2026 · NCT05839379

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

RekruttererFase 1
  • MD Anderson Cancer Center, Houston
36 Months – 22 Years · Alle køn · Opdateret 4. sep. 2026 · NCT03911388

Study of Olutasidenib and Temozolomide in HGG

RekruttererFase 2
  • Texas Children's Hospital, Houston
Alder 12 til 39 · Alle køn · Opdateret 1. sep. 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

RekruttererFase 3
  • MD Anderson Cancer Center, Houston
Alder 18 og opefter · Alle køn · Opdateret 28. aug. 2026 · NCT05303519

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

RekruttererFase 2
  • Texas Children's Hospital, Houston
Alder 3 til 39 · Alle køn · Opdateret 24. aug. 2026 · NCT05096481

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

RekruttererObservationsstudie
  • M D Anderson Cancer Center, Houston
Alle aldre · Alle køn · Opdateret 21. aug. 2026 · NCT01772771

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

RekruttererFase 1/2
  • Research Site, Houston
Alder 18 til 130 · Alle køn · Opdateret 12. aug. 2026 · NCT05417594

Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)

RekruttererFase 1
  • Excel Diagnostics & Nuclear Oncology Center, Houston
Alder 18 og opefter · Alle køn · Opdateret 7. aug. 2026 · NCT07733674

C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)

RekruttererFase 1
  • Texas Children's Hospital, Houston
12 Months – 25 Years · Alle køn · Opdateret 3. aug. 2026 · NCT04099797

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

RekruttererFase 2
  • University of Texas MD Anderson Cancer Center, Houston
Alder 8 og opefter · Alle køn · Opdateret 27. jul. 2026 · NCT05503797

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

RekruttererTidlig fase 1Frivillige med god helbredstilstand velkomne
  • Texas Children's Hospital, Houston
Alder 1 til 21 · Alle køn · Opdateret 29. jun. 2026 · NCT06333899

Window-of-Opportunity Trial of Ulixertinib for MAPK-Activated Gliomas

RekruttererTidlig fase 1
  • M D Anderson Cancer Center, Houston
Alder 18 og opefter · Alle køn · Opdateret 12. jun. 2026 · NCT05804227

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

RekruttererFase 2
  • Texas Children's Hospital, Houston
12 Months – 39 Years · Alle køn · Opdateret 29. maj 2026 · NCT05843253

A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

RekruttererFase 1
  • MD Anderson Cancer Center, Houston
Alder 18 og opefter · Alle køn · Opdateret 20. apr. 2026 · NCT06326411

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

RekruttererFase 1/2
  • MD Anderson Cancer Center, Houston
Alder 18 og opefter · Alle køn · Opdateret 13. apr. 2026 · NCT06810544

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

RekruttererTidlig fase 1
  • Texas Children's Hospital, Houston
Op til 21 år · Alle køn · Opdateret 18. mar. 2026 · NCT04655404

Gliom forsøg i andre byer

Andre studier i Houston

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.